XML 66 R7.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash provided (required) by operating activities of continuing operations:      
Net income (loss) $ 550.6 $ 480.2 $ 511.5
Discontinued operations, net of income taxes 28.3 63.3 26.1
Income (loss) from continuing operations 578.9 543.5 537.6
Adjustments from income (loss) from continuing operations to cash provided (required) by operating activities of continuing operations:      
Depreciation and amortization 162.7 150.1 150.2
Equity in (earnings) loss of affiliates 0.0 0.0 (0.1)
Restructuring and other charges (income) 132.2 171.0 61.2
Deferred income taxes 33.6 46.1 (43.9)
Pension and other postretirement benefits 25.8 12.6 6.1
Share-based compensation 18.9 25.6 22.5
Changes in operating assets and liabilities, net of effect of acquisitions and divestitures:      
Trade receivables, net (71.8) (123.5) (281.5)
Guarantees of vendor financing 64.8 8.6 15.4
Advance payments from customers (145.5) 34.1 80.2
Accrued customer rebates 17.2 (85.8) 104.1
Inventories (59.7) 6.4 (200.7)
Accounts payable, trade and other 61.8 103.0 166.7
Income taxes 36.2 (25.0) (94.7)
Pension and other postretirement benefit contributions (4.6) (13.4) (37.5)
Environmental spending, continuing, net of recoveries (1.9) (18.3) (20.3)
Restructuring and other spending [1] (17.9) (18.6) (25.2)
Transaction and integration costs [1] (63.9) (77.1) (101.1)
Change in other operating assets and liabilities, net (30.0) [2] (183.7) 23.7
Cash provided (required) by operating activities of continuing operations 736.8 555.6 362.7
Cash provided (required) by operating activities of discontinued operations:      
Environmental spending, discontinued, net of recoveries (58.9) (51.7) (41.0)
Operating activities of discontinued operations, net of divestiture costs (0.2) 9.0 74.5
Other discontinued spending (29.9) (24.4) (27.8)
Cash provided (required) by operating activities of discontinued operations (89.0) (67.1) 5.7
Cash provided (required) by investing activities of continuing operations:      
Capital expenditures (67.2) (93.9) (83.0)
Acquisitions, net [3] (65.6) 0.0 19.6
Proceeds from sale of product portfolios 0.0 0.0 88.0
Investment in Enterprise Resource Planning system (47.2) (48.0) (48.5)
Other investing activities [4] (20.4) (54.0) (13.6)
Cash provided (required) by investing activities of continuing operations (200.4) (195.9) (37.5)
Cash provided (required) by investing activities of discontinued operations:      
Proceeds from disposal of property, plant and equipment 31.1 26.2 0.0
Other discontinued investing activities 0.0 (17.0) (93.4)
Cash provided (required) by investing activities of discontinued operations 31.1 9.2 (93.4)
Cash provided (required) by financing activities of continuing operations:      
Increase (decrease) in short-term debt 97.0 (11.9) 79.5
Proceeds from borrowing of long-term debt 27.1 1,500.0 0.0
Financing fees and interest rate swap settlements (3.5) (97.4) (3.1)
Repayments of long-term debt (100.0) (901.9) (552.0)
Acquisitions of noncontrolling interests (7.4) 0.0 0.0
Distributions to noncontrolling interests (1.3) 0.0 0.0
Net proceeds received from initial public offering of FMC Lithium 0.0 0.0 363.6
Dividends paid [5] (228.5) (210.3) (89.2)
Issuances of common stock, net 24.7 50.7 10.7
Repurchases of common stock under publicly announced program (50.0) (400.0) (200.0)
Other repurchases of common stock (8.4) (16.2) (6.8)
Cash provided (required) by financing activities of continuing operations (250.3) (87.0) (397.3)
Cash provided (required) by financing activities of discontinued operations:      
Proceeds from borrowing of long-term debt 0.0 0.0 34.0
Payment of Livent external debt 0.0 (27.0) 0.0
Cash transfer to Livent due to spin 0.0 (10.2) 0.0
Cash provided (required) by financing activities of discontinued operations 0.0 (37.2) 34.0
Effect of exchange rate changes on cash and cash equivalents 1.6 (0.2) 4.5
Increase (decrease) in cash and cash equivalents 229.8 177.4 (121.3)
Cash and cash equivalents of continuing operations, beginning of period 339.1 134.4 281.8
Cash and cash equivalents of discontinued operations, beginning of period [6] 0.0 27.3 1.2
Cash and cash equivalents, beginning of period   339.1 161.7
Less: cash and cash equivalent of discontinued operations, end of period 0.0 0.0 [6] 27.3 [6]
Cash and cash equivalents, end of period $ 568.9 $ 339.1 $ 134.4
[1] The restructuring and other spending amount includes spending of $3.6 million related to the Furadan® asset retirement obligations. For additional detail on restructuring activities, see Note 9 to our consolidated financial statements included within this Form 10-K
[2] Changes in all periods represent timing of payments associated with all other operating assets and liabilities.
[3] The acquisitions, net amount in 2020 represents payments made on October 2, 2020 to acquire the remaining rights for Fluindapyr from Isagro S.p.A ("Isagro") in an asset acquisition. For additional detail on this transaction, see Note 9 to our consolidated financial statements included within this Form 10-K.
[4] Cash spending associated with contract manufacturers was $17.4 million, $51.7 million and $13.1 million for the years ended December 31, 2020, 2019 and 2018, respectively.The accompanying notes are an integral part of these consolidated financial statements.
[5] See Note 17 regarding our quarterly cash dividend.
[6] Reflected within "Current assets of discontinued operations" on the consolidated balance sheets.